Chrome Extension
WeChat Mini Program
Use on ChatGLM

Once-weekly dulaglutide for the treatment of youths with type 2 diabetes

Arslanian SA,Tamara S. Hannon,Philip Zeitler, Chao LC, C Boucher-Berry,Margarita Barrientos-Pérez,Élise Bismuth, Sarah Dib, Chao Ji, Cox D, Investigators Cox AWARD-PEDS

Yearbook of pediatric endocrinology(2023)

Cited 0|Views7
No score
Abstract
Brief summary: This randomized, double-blind, phase 3 trial of youths with inadequately controlled T2D, dulaglutide treatment was superior to placebo in reducing the glycated hemoglobin level at 26 weeks.
More
Translated text
Key words
diabetes,treatment,once-weekly
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined